Clinical Features and Prognosis of Double-Positive Anti-MDA5 and Anti-CCP Antibodies in Dermatomyositis: A Retrospective Study
More than half of the patients with MDA5+/CCP+ DM may present with arthritis as one of the initial symptoms. They may also have an increased risk of malignancy. For MDA5+ DM patients with positive anti-CCP antibodies, thorough screening for tumors is crucial to guide treatment and improve prognosis.
Authors
- Yongpeng Ge (ORCID: https://orcid.org/0000-0003-3674-9307)
- Longyang Zhu
- Guochun Wang (ORCID: https://orcid.org/0000-0002-4616-9376)
- Xinshui Xu (ORCID: https://orcid.org/0000-0001-8828-034X)
- Sizhao Li (ORCID: https://orcid.org/0009-0009-2129-2202)
Institutions
- Peking University (CN)
- China-Japan Friendship Hospital (CN)
- Hainan Medical University (CN)
Publication Details
- Journal
- Journal of Inflammation Research
- Published
- 2025-02-01
- DOI
- https://doi.org/10.2147/jir.s503120
- Primary Topic
- Inflammatory Myopathies and Dermatomyositis
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- China-Japan Friendship Hospital